Bård Bjørnarå

ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study)

Øivind Torkildsen, Stig Wergeland, S. J. Bakke et al. · Archives of Neurology · 2012 · 145 citations

Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment

Kristin I. Løken-Amsrud, Trygve Holmøy, S. J. Bakke et al. · Neurology · 2012 · 105 citations

Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis

Kristin I. Løken-Amsrud, Kjell‐Morten Myhr, S. J. Bakke et al. · Multiple Sclerosis Journal · 2012 · 49 citations

Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital

Ola E. Dahl, T. E. Gudmundsen, Bård Bjørnarå et al. · Acta Orthopaedica Scandinavica · 2003 · 36 citations

Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis – Association and Prediction

Kristin I. Løken-Amsrud, Kjell‐Morten Myhr, S. J. Bakke et al. · PLoS ONE · 2013 · 25 citations · Full text